These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6110093)

  • 81. Somatostatin inhibits insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF) in duodenal ulcer patients.
    Schrumpf E; Vatn MH; Hanssen KF; Semb S; Myren J
    Scand J Gastroenterol; 1976; 11(5):517-20. PubMed ID: 785589
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Plasma gastrin and gastric secretory response to duodenal perfusion with liver extract in healthy human subjects.
    Grabner P; Semb LS; Schrumpf E; Myren J
    Scand J Gastroenterol; 1977; 12(7):865-8. PubMed ID: 339324
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The influence of various secretory inhibitors on peptic activity.
    Gabryelewicz A; Laszewicz W; Sarosiek J
    Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease.
    Jaup BH; Stockbrügger R; Dotevall G
    Scand J Gastroenterol; 1979; 14(5):621-4. PubMed ID: 493866
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inhibition of pentagastrin-stimulated secretion of acid and pepsin by trimipramine in man.
    Berstad A; Roland M; Myren J
    Scand J Gastroenterol Suppl; 1976; 42():123-5. PubMed ID: 796964
    [No Abstract]   [Full Text] [Related]  

  • 86. Sensitivity of the oxyntic and peptic cells to pentagastrin in duodenal ulcer patients and healthy subjects with similar secretory capacity.
    Aly A; Emås S
    Digestion; 1982; 25(2):88-95. PubMed ID: 6816648
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The effect of carbachol and pentagastrin on the gastric secretion of acid pepsin, and intrinsic factor (IF) in man.
    Vatn MH; Schrumpf E; Myren J
    Scand J Gastroenterol; 1975; 10(1):55-8. PubMed ID: 235784
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Implication of gastric mucosal histamine in inhibition by isoprenaline of pentagastrin-induced gastric secretion.
    Lundell L; Svensson SE
    Br J Pharmacol; 1974 Sep; 52(1):69-75. PubMed ID: 4155986
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antral acidification and the gastric secretory response to pentagastrin and acetylcholine in dogs.
    Wheeler MH; Prescott RJ; Forrest AP
    Br J Surg; 1974 Aug; 61(8):605-10. PubMed ID: 4604114
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The inhibitory effect of sulpiride on pentagastrin-stimulated gastric secretion.
    Aune S; Stadaas JO
    Scand J Gastroenterol; 1972; 7(8):713-5. PubMed ID: 4640649
    [No Abstract]   [Full Text] [Related]  

  • 91. Effect of atropine on insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF).
    Schrumpf E; Vatn MH; Semb LS
    Scand J Gastroenterol; 1974; 9(7):665-9. PubMed ID: 4610710
    [No Abstract]   [Full Text] [Related]  

  • 92. N,N-dimethyl-10-(3-quinuclidinyl)-2-phenothiazine sulfonamide (LM 24056): mode of action of its gastric antisecretory effect.
    Vatier J; Bessac JF; Bonfils S
    Arzneimittelforschung; 1983; 33(11):1573-6. PubMed ID: 6140926
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibition of gastric secretion by exogenous secretin and cholecystokinin in normals and duodenal ulcer patients.
    Jörgensen SP; Henriksen FW
    Scand J Gastroenterol Suppl; 1976; 37():39-42. PubMed ID: 1064138
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients.
    Dal Santo PL; Vianello F; Germana B; Dotto P; Laino G; Del Bianco T; Plebani M; Leandro G; Savarino V; Di Mario F
    Z Gastroenterol; 1993 Jan; 31(1):11-4. PubMed ID: 8447149
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of medical vagotomy on acid and pepsin responses to histamine and pentagastrin in man.
    Konturek SJ; Szybiński Z; Horzela T
    Scand J Gastroenterol; 1967; 2(4):311-5. PubMed ID: 4865177
    [No Abstract]   [Full Text] [Related]  

  • 96. Aspects of basal gastric secretion in man.
    Saunders JH; Thjodleifsson B; Wormsley KG
    Digestion; 1975; 12(3):183-8. PubMed ID: 1183751
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The effect of tripotassium dicitrato bismuthate on pepsin activity.
    De Beaux AC; Defize J; Hunt RH
    Aliment Pharmacol Ther; 1989 Aug; 3(4):381-5. PubMed ID: 2518852
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intragastric titration of peptone-stimulated gastric acid secretion.
    Kisfalvi I
    Acta Med Acad Sci Hung; 1978; 35(2):99-104. PubMed ID: 742344
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Gastric functional exploration. Comparison between secretory results in 72 non-ulcer dyspeptic patients and 289 non-operated duodenal ulcer patients. Predictive criteria for the efficacy of fundus vagotomy in duodenal ulcer].
    Vatier J; Poitevin C; Pasquier MC; Vitré MT; Olivier A; Sfedj D; Mignon M
    Gastroenterol Clin Biol; 1991; 15(10):727-34. PubMed ID: 1816013
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Reaction of HCl secretion, total proteolytic activity and pepsin after a selective proximal vagotomy in duodenal ulcer patients].
    Lindenschmidt EG; Becker HD
    Chirurg; 1979 Aug; 50(8):498-502. PubMed ID: 391513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.